🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

App-based Motivational Interviewing and Artificial Intelligence in Diabetes Management

RecruitingNAAges 21 Years - 100 YearsAllSingapore General Hospital
NCT06214520 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

There is an urgent need for better control and prevention of complications in type 2 diabetes mellitus (T2DM). Behavioural change is critical, and while literature suggests that motivational interviewing (MI) may be effective in improving glycemic control, none has explored app-based MI designed specifically for T2DM. The overall objective of this project is to determine the effectiveness of primary care model combining app-based MI and AI-powered personalised nudges delivered through a mobile application (app) for diabetes management (EMPOWER-PLUS). The project aims to evaluate the effectiveness and implementation of MI and nudges through EMPOWERPLUS to deliver diabetes management through a randomised controlled trial (RCT). This will be a 3-arm RCT with primary outcome measure being the difference in HbA1c level at week 36 between the intervention and control arms. Secondary outcome me

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Aged 21 years and above * Have been diagnosed with diabetes (T2DM) * Had HbA1c result of ≥ 7.5% within past 3 months * Physically able to exercise * Able to read and converse in English * Able to download the Empower+ app, use the smartphone wearable tracker, and conform to the minimum smartwatch and app monitoring schedule Exclusion Criteria: * On bolus insulin treatment * Require assistance with basic activities of daily living (BADL) * Have planned major operation or surgical procedure within 9 months from the time of recruitment * Cognitively impaired (scored \< 6 on the Abbreviated Mental Test) * Currently pregnant or lactating * Current participants of ongoing clinical trials involving the usage of a smartphone wearable tracker or mobile health app to assist diabetes management * Past Empower study participants who refused to participate in future Empower studies
💊

What it tests

  • App-based Motivational Interviewing & Human health coaching
  • Empower+ App & Smartwatch wearable tracker
📍

Where

3 sites
SingHealth Polyclinic (Punggol)
Singapore, Singapore
SingHealth Polyclinic (Sengkang)
Singapore, Singapore
SingHealth Polyclinic (Tampines)
Singapore, Singapore
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy